This week, we speak to Emma Clayton, CEO of Grey Bear Consultancy, about the journey to starting her own agency, pharma communications in the COVID-19 era, and empowering women to succeed in the workplace.

Michaila is joined by Pierre van Weperen, Chief Commercial Officer of Grow Biotech. Together they explore the potential of medicinal cannabis and consider the differences between working in big pharma vs in a start-up...

This week, we speak to Dr. William Soliman, Chairman and CEO, of the Accreditation Council for Medical Affairs, about establishing industry benchmarks, what it is like to join the field now, and what it means to be a futurist in medical affairs.

Sen looks back at the past month in pharma, examining the progress of treatment and vaccine efforts against COVID-19, and highlighting some positive industry news that has emerged despite the on-going pandemic.

In this special episode, Spencer interviews an NHS doctor on the frontline of COVID-19 and a patient who has just recovered from the virus, unpacking this unprecedented situation from both perspectives.

This week, Spencer sits down with Claire Gillis, International CEO, WPP Health Practice, who discusses WPP's work with the ABC Global Alliance, how the communications role can transform patient outcomes, and the proudest moments from her career so far.

Sen is joined in the studio by Arpita Pani, Senior Commercial Governance, Digital and e-commerce lead at Ferring Pharmaceuticals. Arpita discusses the evolution and future of digital marketing in pharma, including the industry's use of social media.

Dan discusses digital health with Julien De Salaberry, an expert in health tech, who has worked across the pharma and start-up sectors, striving to solve healthcare pain points with technological innovation.

We reflect on EMG-Health's recent trip to business guru, Grant Cardone's, 10X Growth Conference in Las Vegas. With CEO, Spencer Gore, and Performance Manager, Darren Brace, revealing their key highlights and takeaways from the event.

Following the coronavirus outbreak, European congress attendance is down and events are being postponed. We sit down with Professor Jonathan Sackier to dispel the myths around the virus and discuss why it's important for pharma to find alternative ways of sharing their research.